SMAD3 and focal segmental glomerulosclerosis: FSP-1 has been shown to enhance fibrosis via TGF-β/Smad3 signaling, a pathway implicated in other CKDs, including IgAN, DN, and focal segmental glomerulosclerosis (FSGS) [26].